- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06596070
Clinical Study of Intestinal Barrier Dysfunction After Gastrointestinal Surgery
September 12, 2024 updated by: Weiming Li, The Second Affiliated Hospital of Kunming Medical University
Clinical Study of Intestinal Barrier Dysfunction in Patients After Gastrointestinal Surgery
The goal of this observational study is to explore the clinical influences associated with the development of intestinal barrier dysfunction in patients undergoing gastrointestinal surgery.
The main question it aims to answer is:What clinical factors increase the probability of developing intestinal barrier dysfunction in patients after gastrointestinal surgery?
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
180
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: weiming Li
- Phone Number: 13114225597
- Email: liweiming49@163.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
People undergoing gastrointestinal surgery
Description
Inclusion Criteria:
- men or women aged 18-80 years
- expected feasible abdominal surgical treatment (partial gastrectomy, colorectal resection)
- no preoperative intestinal barrier dysfunction
- patients voluntarily participated in this study and signed an informed consent form.
Exclusion Criteria:
- Patients or their families refused to participate in this study
- chronic inflammatory diseases (e.g. inflammatory bowel disease, chronic hepatitis, chronic pancreatitis, chronic peptic ulcer, etc.)
- history of antibiotic administration in the last 2 weeks
- severe cognitive impairment and other inability to cooperate preoperative neoadjuvant radiotherapy
- combined with severe hepatic, renal, and cardiac insufficiency patients.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Intestinal barrier dysfunction group
|
This study is an observational study and no intervention was performed on the patients.
|
|
Non-intestinal barrier dysfunction group
|
This study is an observational study and no intervention was performed on the patients.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
operating time
Time Frame: During surgery
|
Record the patient's surgical time
|
During surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
nutritional status
Time Frame: Preoperative
|
Patients were assessed for risk of malnutrition by the Nutritional Risk Screening Scale (NRS-2002).
A score of ≥3 indicated that the patient was at risk of malnutrition.
|
Preoperative
|
|
bowel habit
Time Frame: Preoperative
|
The patient was asked whether there were increased frequency of stool, changes in stool characteristics, constipation and other conditions before surgery
|
Preoperative
|
|
Surgical Procedures
Time Frame: During surgery
|
Record whether the patient underwent laparoscopic surgery or open surgery
|
During surgery
|
|
hemorrhage
Time Frame: During surgery
|
Record the patient's intraoperative bleeding volume
|
During surgery
|
|
Albumin
Time Frame: Preoperative and postoperative 24 hours
|
Record the patient's albumin levels before and 24 hours after surgery
|
Preoperative and postoperative 24 hours
|
|
Infection indicators
Time Frame: Preoperative and postoperative 24 hours
|
Record the values of PCT, IL-6, and CRP of patients before and 24 hours after surgery
|
Preoperative and postoperative 24 hours
|
|
age
Time Frame: Preoperative
|
Preoperative
|
|
|
gender
Time Frame: Preoperative
|
Preoperative
|
|
|
Body Mass Index
Time Frame: Preoperative
|
Preoperative
|
|
|
diabetes
Time Frame: Preoperative
|
Record whether the patient has diabetes
|
Preoperative
|
|
enteral nutrition
Time Frame: The average observation time is 2 weeks after surgery.
|
Record the start time of enteral nutrition for patients after surgery.
|
The average observation time is 2 weeks after surgery.
|
|
Exhaust and defecation time
Time Frame: The average observation time is one week after surgery
|
Record the time of the patient's first exhaust and first bowel movement after surgery
|
The average observation time is one week after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
October 1, 2024
Primary Completion (Estimated)
January 1, 2025
Study Completion (Estimated)
April 1, 2025
Study Registration Dates
First Submitted
September 7, 2024
First Submitted That Met QC Criteria
September 12, 2024
First Posted (Estimated)
September 19, 2024
Study Record Updates
Last Update Posted (Estimated)
September 19, 2024
Last Update Submitted That Met QC Criteria
September 12, 2024
Last Verified
September 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- PJ-2024-124
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
Research not yet completed
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intestinal Barrier Dysfunction
-
Queen Mary University of LondonCompletedIntestinal Barrier DysfunctionUnited Kingdom
-
Wuhan Union Hospital, ChinaNot yet recruitingGastrointestinal Dysfunction | Traditional Chinese Acupoint Message | Intestinal BarrierChina
-
University of FloridaLallemand Health SolutionsCompletedIntestinal Barrier FunctionUnited States
-
Wageningen University and ResearchCompletedProtein Digestion Kinetics | Intestinal Barrier FunctionNetherlands
-
University Hospital, Gentofte, CopenhagenUniversity of CopenhagenCompletedNeurodegenerative Disease | Obesity (Disorder) | Blood Brain Barrier | Intestinal Barrier Dysfunction | Systemic Inflammation MarkersDenmark
-
Taoyuan Armed Forces General HospitalCompletedDermatitis | Incontinence-Associated Dermatitis | Skin Barrier DysfunctionTaiwan
-
Rush University Medical CenterUniversity of Alberta; University of Nebraska LincolnCompletedIntestinal Microbiota and Barrier FunctionUnited States
-
University of Split, School of MedicineRecruitingSkin Hydration | Skin Barrier Function | Topical Peptide Effects on Facial Skin Barrier FunctionCroatia
-
The First Affiliated Hospital of Anhui Medical...Hangzhou Cancer HospitalCompletedPostoperative Cognitive Dysfunction | Endothelial Dysfunction | Blood Brain Barrier DefectChina
-
L'OrealActive, not recruitingImpaired BarrierChina
Clinical Trials on No intervention was carried out
-
Ying ZhangXiyuan Hospital of China Academy of Chinese Medical Sciences; Dongzhimen Hospital... and other collaboratorsNot yet recruiting
-
Aga Khan UniversityCompletedGender IssuesPakistan
-
Qi-Yong LiActive, not recruitingGallstones | Choledocholithiasis | Cholangiopancreatography, Endoscopic RetrogradeChina
-
Exactis InnovationKnight TherapeuticsCompleted
-
Centro Hospitalar Tondela-ViseuPortuguese IBD GroupCompletedInflammatory Bowel Diseases | Coagulation Disorder | ThromboembolismPortugal
-
Marmara UniversityCompletedHyperlipidemia, Periodontal Disease
-
Beaujon HospitalCompletedMorality | Gender Bias | Physical RestraintFrance
-
Aga Khan UniversityCompletedBreast Cancer | Perforator Flap | Breast Tumor | Oncoplasty | Breast-QPakistan
-
Jessa HospitalCompletedColorectal Disorders | Complication of Surgical Procedure | Clavien Dindo | Comprehensive Complication IndexBelgium